TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
BIOA

BioAge Labs, Inc

Healthcare · Drug Manufacturers - Specialty & Generic · —

8.10$ -0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement BIOA
Line item 2013 2014 2015 2016 2017 2022 2023 2024 2025
-42.1% +40.8% +280.9% +80.6% -100.0%
+124.8% -56.8% +423.1% +63.3%
-8.6% +33.8% -64.5% -24.0% +458.3% +11.0% +74.2% +25.3%
+22.8% +6.8% -0.7% +59.1% -9.3% +53.6% +32.0% +45.2%
-25.4% +24.0% -36.4% +323.5% -61.1% +21.1% +61.6% +30.2%
+3,134.0% -69.6% -70.6%
-26.7% -105.0% +218.7% +194.9% +3,134.0% -1,012.4%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?